Evento
Evidence of cannabinoid modulation in nuclear signaling
Colaboradores:
Kotsias, Basilio Aristides
; de Vito, Eduardo
; Narvaiz Kantor, Isabel; Semeniuk, Guillermo Basilio
Tipo del evento:
Congreso
Nombre del evento:
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica (SAIC); LI Reunión Anual de la Asociación Argentina de Farmacología Experimental (SAFE); XXI Reunión Anual de la Sociedad Argentina de Biología (SAB); XXXI Reunión Anual de la Sociedad Argentina de Protozoología (SAP); IX Reunión Anual de la Asociación Argentina de Nanomedicinas (NANOMED-ar); VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio (AACyTAL)
Fecha del evento:
13/11/2019
Institución Organizadora:
Sociedad Argentina de Investigación Clínica;
Asociación Argentina de Farmacología Experimental;
Sociedad Argentina de Biología;
Sociedad Argentina de Protozoología;
Asociación Argentina de Nanomedicinas;
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio;
The Histochemical Society;
Título de la revista:
Medicina (Buenos Aires)
Editorial:
Fundación Revista Medicina (Buenos Aires)
ISSN:
0025-7680
e-ISSN:
1669-9106
Idioma:
Inglés
Clasificación temática:
Resumen
The endocannabinoid system (ECS) is a signaling mechanism involved in many pathophysiological processes, especially in the nervous system. Former studies from our lab demonstrated the presence of the different components of the ECS in nuclei from rat cerebellum and cerebral cortex (CC). We detected diacylglycerol lipase and monoacylglycerol lipase activities which are involved in maintaining the levels of the endocannabinoid 2-arachidonoyl-glycerol. In addition, we demonstrated a nuclear CB1 protein expression by Western Blot and immunocytochemistry. CB1 is a GPCR receptor that triggers different signaling cascades, modulating intracellular Ca²+ levels, ERK1/2 phosphorylation, and other second messengers at the plasma membrane. Nevertheless, we also observed an increase in ERK phosphorylation in isolated nuclei from rat cerebral cortex (CCN) incubated with a CB1 synthetic agonist (WIN 55-212-2). Phosphorylated ERK could be involved in activating MSK1/2, a nuclear kinase that phosphorylates histone 3 (H3). The aim of this work was therefore to study how a cannabinoid agonist modulates ERK1/2 and H3 phosphorylation in CCN. To this end, CC from Wistar rats were dissected and homogenized, and highly purified nuclei (CCN) were isolated on a sucrose-density ultracentrifugation. CCN were subsequently incubated at 37 °C with WIN and ERK1/2 and H3 signaling cascades were studied by Western Blot. Interestingly, it was observed that ERK1/2 and H3 phosphorylation increased in nuclei treated with WIN 5 µM for 30 min with respect to controls (p<0.05). As expected, this was reversed by pre-incubating for 10 min with a MEK inhibitor (U0126, 10 µM), however, no changes were observed when a CB1 antagonist (SR141716, 1 µM) was used (p<0.05). Taken together, these results demonstrate that cannabinoids at nuclear level could modulate H3 phosphorylation by ERK1/2 signaling. This indicates a potential role of these lipids in chromatin regulation and gene expression in cerebral cortex
Palabras clave:
CANNABINOIDS
,
NUCLEI
,
CEREBRAL CORTEX
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(INIBIBB)
Eventos de INST.DE INVEST.BIOQUIMICAS BAHIA BLANCA (I)
Eventos de INST.DE INVEST.BIOQUIMICAS BAHIA BLANCA (I)
Citación
Evidence of cannabinoid modulation in nuclear signaling; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica (SAIC); LI Reunión Anual de la Asociación Argentina de Farmacología Experimental (SAFE); XXI Reunión Anual de la Sociedad Argentina de Biología (SAB); XXXI Reunión Anual de la Sociedad Argentina de Protozoología (SAP); IX Reunión Anual de la Asociación Argentina de Nanomedicinas (NANOMED-ar); VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio (AACyTAL); Mar del Plata; Argentina; 2019; 141-142
Compartir